Investors Must-Watch: Tenet Healthcare Corp. (NYSE:THC)

The stock lost about -7 percent in price since last results when it was at $19.71 a share. The price targets are usually acts as the boosters or blasters in the performance of stock. For the quarter, revenue came in at 4.85B versus consensus estimate of 4.78B. The stock's quarterly performance indicates a Positive momentum of 17.97 percent, whereas its last one month trend is Optimistic with 7.31 percent.

Many research firms have provided their ratings on Tenet Healthcare Corp. (NYSE:THC)'s Buy count is 0 and Strong Buy is 5 while the number of analysts recommending Sell and Strong Sell are 0 and 8, respectively. For trailing twelve months, EPS value for the stock is $-2.10. (NYSE:THC) to Peer Perform with no specific Price Target. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and seven have assigned a buy rating to the company's stock. 15 Analysts reported that the Price Target for Tenet Healthcare Corp. might touch $38 high while the Average Price Target and Low price Target is $24 and $13 respectively.

Analysts' mean recommendation for Tenet Healthcare Corp.'s (THC) stands at 2.70.

The Relative Volume of the company is 1.42 and Average Volume (3 months) is 2.53 million. While it's Return on Investment (ROI) value is 6.5%. This scale runs from 1 to 5 where 1 represents Strong Buy and 5 represents Sell. (Liquidity) Value. Tenet Healthcare Corp. (NYSE:THC) could bring EPS of $0.19/share. Looking ahead to earnings forecasts, for the running fiscal period, Wall Street analysts have anticipated that the company will report 0.20 earnings per share. This showed the surprise of -15.8% in the last quarter earnings. The reported earnings per share topped the analyst's consensus by $0.1 with the percentage difference between estimated and actual earnings arriving at 14.70%. The company has a market cap of $1,930 million and there are 99,635,674 shares in outstanding.

Shares of Tenet Healthcare Corp (NYSE:THC) declined -0.56% to $19.37. The stock was trading on below-average volume. The stock gained 0.98% the day following the earnings data was made public, and on 7th day price change was -1.58%. The stock is now moving above its 20-Day Simple Moving Average of 22.03% with the 50-Day Simple Moving Average of 22.03 percent. THC has P/E (Price to Earnings ttm) value of 0, Forward P/E of 9.94, P/C (Price to cash per share) of 2.97 and Price to Free Cash Flow (P/FCF) value of 12.7. The Moving Average SMA50 is 14.17% while SMA200 is -14.98%.

The company shows its Return on Assets (ROA) value of -0.9%. The stock now shows its YTD (Year to Date) performance of 30.53 percent while its Weekly performance value is 2.11%. The Stock has YTD (year to date) performance of 40.16 percent. Raymond James Financial, Inc. downgraded shares of Tenet Healthcare Corporation from an "outperform" rating to a "market perform" rating in a research note on Thursday, November 10th. The shares have accelerated in recent weeks, with their price up about 17.97% in the past three months. Net profit margin of the company was recorded at -1.1 percent, operating profit margin was 6.4 percent, whereas gross profit margin stands at 84 percent.

  • Joanne Flowers